Reduction of LDL receptor (LDLR) expression and LDL uptake, by either enhancing receptor degradation11, or genetic manipulation reduced tumor growth in pre-clinical pancreatic and breast cancer models5,10, providing evidence for the association between lipoprotein uptake and the promotion of tumor progression in some cancers. This evidence concerns the gene LDLR and neoplasm.